Last reviewed · How we verify
Coartem®, Novartis
At a glance
| Generic name | Coartem®, Novartis |
|---|---|
| Also known as | RIAMET |
| Sponsor | Epicentre |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Coartem®, Novartis CI brief — competitive landscape report
- Coartem®, Novartis updates RSS · CI watch RSS
- Epicentre portfolio CI